General Archive
-
News releasesLifeArc-funded trial gives new hope for children with devastating rare genetic disorder
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his…
-
The use of CARBALIVE in the treatment of cholestatic liver disease
-
News releasesBirmingham researchers lead world-first trial for rare liver disease treatment funded by LifeArc
University Hospitals Birmingham NHS Foundation Trust (UHB) has treated the first patient in an early-phase clinical trial investigating whether a…
-
ART-EB: An innovative drug repurposing trial to find treatments for a rare skin disorder
ART-EB: An innovative drug repurposing trial to find treatments for a rare skin disorder We’ve partnered with DEBRA UK to…
-
Transforming Diagnosis and Treatment: Rare Disease Summit
About the event The Rare Disease Summit will explore how the UK can accelerate progress in diagnosing those living with…
-
ArticlesLifeArc Pathfinder Award recipients uncover genetic cause of severe nerve condition in children
Researchers at the University of Manchester have identified a rare genetic mutation that causes severe nerve damage in children following mild infections. Their findings…
-
ArticlesLifeArc and Genetic Alliance UK launch a new report calling for the acceleration of research and development (R&D) for rare diseases
LifeArc and Genetic Alliance UK have launched a report calling for the UK Government, NHS, researchers, industry, patient groups and…
-
Accelerating R&D for rare disease in the UK: An opportunity to change millions of lives
This report is a call to transform the UK’s rare disease future. It outlines how we can smooth the rare…
-
Rare Disease Clinical Trials Programme
Rare Disease Clinical Trials Programme Our Rare Disease Clinical Trials Programme aims to progress innovations that could change the lives…
-
Articles, News releasesLifeArc joins the REMEDi4ALL Consortium, a pioneering global platform shaping the future of drug repurposing
LifeArc and the EU-funded project, REMEDi4ALL, have announced a collaboration agreement to strengthen the partnership’s potential to transform and accelerate…
-
News releases£1 million partnership aims to develop new treatments for congenital muscular dystrophy
Researchers from University College London have jointly received a £1 million grant from LifeArc and Muscular Dystrophy UK, to develop…
-
Muscular Dystrophy UK: A £1 million partnership to find new treatments for congenital muscular dystrophy
Muscular Dystrophy UK: A £1 million partnership to find new treatments for congenital muscular dystrophy We’ve partnered with Muscular Dystrophy…